Literature DB >> 9811884

Mechanisms of beta cell death in diabetes: a minor role for CD95.

J Allison1, A Strasser.   

Abstract

Insulin-dependent diabetes mellitus is an autoimmune disease, under polygenic control, manifested only when >90% of the insulin-producing beta cells are destroyed. Although the disease is T cell mediated, the demise of the beta cell results from a number of different insults from the immune system. It has been proposed that foremost amongst these effector mechanisms is CD95 ligand-induced beta cell death. Using the nonobese diabetic lpr mouse as a model system, we have found, to the contrary, that CD95 plays only a minor role in the death of beta cells. Islet grafts from nonobese diabetic mice that carry the lpr mutation and therefore lack CD95 were protected only marginally from immune attack when grafted into diabetic mice. An explanation to reconcile these differing results is provided.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811884      PMCID: PMC24908          DOI: 10.1073/pnas.95.23.13818

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Apoptosis by death factor.

Authors:  S Nagata
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.

Authors:  J K Wang; B Zhu; S T Ju; J Tschopp; A Marshak-Rothstein
Journal:  Cell Immunol       Date:  1997-08-01       Impact factor: 4.868

3.  Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.

Authors:  P Bobé; D Bonardelle; M Reynès; F Godeau; J Mahiou; V Joulin; N Kiger
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

4.  The role of Fas in autoimmune diabetes.

Authors:  A V Chervonsky; Y Wang; F S Wong; I Visintin; R A Flavell; C A Janeway; L A Matis
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

5.  Beta cell apoptosis in T cell-mediated autoimmune diabetes.

Authors:  M O Kurrer; S V Pakala; H L Hanson; J D Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

6.  Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.

Authors:  L S Wicker; B J Miller; Y Mullen
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

7.  Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus.

Authors:  G Stassi; R De Maria; G Trucco; W Rudert; R Testi; A Galluzzo; C Giordano; M Trucco
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

8.  Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.

Authors:  D Kägi; B Odermatt; P Seiler; R M Zinkernagel; T W Mak; H Hengartner
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

9.  Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.

Authors:  N Itoh; A Imagawa; T Hanafusa; M Waguri; K Yamamoto; H Iwahashi; M Moriwaki; H Nakajima; J Miyagawa; M Namba; S Makino; S Nagata; N Kono; Y Matsuzawa
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

Review 10.  Association of lpr gene with graft-vs.-host disease-like syndrome.

Authors:  A N Theofilopoulos; R S Balderas; Y Gozes; M T Aguado; L M Hang; P R Morrow; F J Dixon
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  23 in total

1.  Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice.

Authors:  E Chang; L Galle; D Maggs; D M Estes; W J Mitchell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 3.  The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

Authors:  H T Kreuwel; L A Sherman
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

4.  Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages.

Authors:  Ritsuko Oura; Rieko Arakaki; Akiko Yamada; Yasusei Kudo; Eiji Tanaka; Yoshio Hayashi; Naozumi Ishimaru
Journal:  J Immunol       Date:  2012-12-19       Impact factor: 5.422

Review 5.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

6.  IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

Authors:  A Amrani; J Verdaguer; S Thiessen; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

7.  A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

Authors:  P L Herrera; D M Harlan; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

8.  Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.

Authors:  Zuoxiang Xiao; Abdiaziz S Mohamood; Sophia Uddin; Rachel Gutfreund; Chiaki Nakata; Andrew Marshall; Hiroaki Kimura; Patrizio Caturegli; Karl L Womer; Yanfei Huang; Chunfa Jie; Shukti Chakravarti; Jonathan P Schneck; Hideo Yagita; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2011-06-15       Impact factor: 4.307

Review 9.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

10.  Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.

Authors:  Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.